The erbB-2 gene is amplified and overexpressed in approximately one-fourth of breast cancer specimens, and it is overexpressed without gene amplification in an additional 5% to 10% of patients. The repeated observation that erbB-2 overexpression is an indicator of poor prognosis, coupled with the evidence which indicates that erbB-2 has transforming potential both in vivo and in vitro, provide strong evidence that this gene plays a direct and causal role in human breast cancer progression. In studies with both rodent and human breast cancer cells, the principal investigator has repeatedly observed that constitutive activation of erbB-2 is associated with growth factor independent proliferation of the cells. This suggests that overexpression of erbB-2 in breast cancer is a likely mechanism by which cells become autonomous of growth factors for proliferation. Nevertheless, a direct and causal link between overexpression of erbB-2 and growth factor independent proliferation has yet to be established. To examine this, the following studies will be carried out.
Aim 1. To determine if progressive overexpression of erbB-2 in normal human mammary epithelial cells that are strictly growth factor dependent for proliferation results in the gradual acquisition of growth factor independent proliferation. Further, the principal investigator will determine if the level of erbB-2 overexpression determines the extent of growth factor independent proliferation.
Aim 2. To determine the role of a stimulatory ligand in constitutive activation of erbB-2 in cells that overexpress the receptor. It is clear that overexpression of erbB-2 in breast cancer cells yields receptors that are constitutively tyrosine phosphorylated to high levels in the absence of exogenous stimulatory ligand. What is unclear is whether autocrine or juxtacrine activation of these receptors is necessary for this high level activation, or whether receptor overexpression alone is sufficient to yield constitutive activation of these receptors.
Aim 3. To determine the role of erbB-3 in constitutive activation of erbB-2 and growth factor independent proliferation of human breast cancer cells that overexpress erbB-2. It is known that in normal cells, heregulin-induced activation of erbB-2 requires the presence of erbB-3. However, it is not known whether erbB-3 plays a role in erbB-2 activation and signal transduction when erbB-2 is overexpressed or whether erbB-2 acts independently of erbB-3 when the former is expressed to high levels.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070354-03
Application #
2700671
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Freeman, Colette S
Project Start
1996-07-01
Project End
2000-04-30
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Willmarth, Nicole E; Baillo, Andrea; Dziubinski, Michele L et al. (2009) Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell Signal 21:212-9
Yang, Zeng-Quan; Moffa, Allison B; Haddad, Ramsi et al. (2007) Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. Int J Cancer 121:1265-73
Moffa, Allison B; Ethier, Stephen P (2007) Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells. J Cell Physiol 210:720-31
Yang, Zeng Quan; Streicher, Katie L; Ray, Michael E et al. (2006) Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res 66:11632-43
Willmarth, Nicole E; Ethier, Stephen P (2006) Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J Biol Chem 281:37728-37
Woods Ignatoski, Kathleen M; Dziubinski, Michele L; Ammerman, Cheryl et al. (2005) Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells. Neoplasia 7:788-98
Yang, Zeng-Quan; Albertson, Donna; Ethier, Stephen P (2004) Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Cancer Genet Cytogenet 155:57-62
Ray, Michael E; Yang, Zeng Quan; Albertson, Donna et al. (2004) Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 64:40-7
Jia, Yifeng; Zeng, Zhao-Zhu; Markwart, Sonja M et al. (2004) Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res 64:8674-81
Woods Ignatoski, Kathleen M; Grewal, Navdeep K; Markwart, Sonja et al. (2003) p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion. Neoplasia 5:128-34

Showing the most recent 10 out of 16 publications